Sakar Healthcare Limited (SAKAR.NS)

INR 310.45

(-0.34%)

Market Cap (In INR)

6.75 Billion

Revenue (In INR)

1.54 Billion

Net Income (In INR)

116.7 Million

Avg. Volume

29.14 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
279.85-479.0
PE
-
EPS
-
Beta Value
0.394
ISIN
INE732S01012
CUSIP
Y7455Q100
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Sanjay Surendra Shah
Employee Count
-
Website
https://www.sakarhealthcare.com
Ipo Date
2017-03-16
Details
Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable SVP in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in approximately 22 therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The company also exports its products to approximately 38 countries, including Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.